Institutional investors purchased a net $871.2 thousand shares of SRPT during the quarter ended September 2014, and now own 64.51% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NPC OF AMERICA Bought 7.6 Thousand shares of Sarepta Therapeutics Inc
APO ASSET MANAGEMENT GMBH Bought 5.1 Thousand shares of Sarepta Therapeutics Inc